Antiviral Drug News and Research

RSS
New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

Can melatonin help prevent severe COVID-19?

Can melatonin help prevent severe COVID-19?

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Ipom-F inhibits SARS-CoV-2 infection in vitro

Ipom-F inhibits SARS-CoV-2 infection in vitro

Phycobilins found to inhibit SARS-CoV-2 enzymes in vitro

Phycobilins found to inhibit SARS-CoV-2 enzymes in vitro

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

Chemists discover effective inhibitors to block SARS-CoV-2

Chemists discover effective inhibitors to block SARS-CoV-2

New strategy for designing COVID-19 antiviral drugs to inhibit key viral protein

New strategy for designing COVID-19 antiviral drugs to inhibit key viral protein

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Research shows how remdesivir inhibits SARS-CoV-2 replication

Research shows how remdesivir inhibits SARS-CoV-2 replication

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Important structures of SARS-CoV-2 PLpro protease

Important structures of SARS-CoV-2 PLpro protease

First antiviral treatment for COVID-19 receives FDA approval

First antiviral treatment for COVID-19 receives FDA approval

SARS-CoV-2 hijacks mitochondria

SARS-CoV-2 hijacks mitochondria

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain could guide design of antiviral agents

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain could guide design of antiviral agents

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Scientists discover a novel antiviral strategy for treating COVID-19

Scientists discover a novel antiviral strategy for treating COVID-19

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters